MX2007009353A - Ciclohexilamidas como antagonistas de la dopamina d3, d2 y 5ht1a. - Google Patents
Ciclohexilamidas como antagonistas de la dopamina d3, d2 y 5ht1a.Info
- Publication number
- MX2007009353A MX2007009353A MX2007009353A MX2007009353A MX2007009353A MX 2007009353 A MX2007009353 A MX 2007009353A MX 2007009353 A MX2007009353 A MX 2007009353A MX 2007009353 A MX2007009353 A MX 2007009353A MX 2007009353 A MX2007009353 A MX 2007009353A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- dopamine
- heteroaryl
- cycloalkyl
- alkenyl
- Prior art date
Links
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title abstract 6
- 229960003638 dopamine Drugs 0.000 title abstract 3
- 101100268471 Rattus norvegicus Htr1a gene Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical class NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 title 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 6
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008196 pharmacological composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La presente invencion se refiere a nuevos ligandos preferentes del subtipo de los receptores de la dopamina D3 y D2 y de la serotonina 5-HT1A, de formula (I), (ver formula (I)) caracterizados porque A representa alquilo, alquenilo, arilo, heteroarilo, cicloalquilo o un grupo de formula -NR1R2 donde R1 y R2 representan, independientemente, un sustituyente seleccionado de entre hidrogeno, alquilo, alquenilo, arilo, heteroarilo o cicloalquilo o R1 y R2 forman, junto con el atomo de nitrogeno adyacente y opcionalmente con otro(s) heteroatomo(s), un anillo heterociclico; m es un numero entero de 0 a 1; n es un numero entero de 1 a 2; y/o los isomeros geometricos y/o los estereoisomeros y/o los diastereomeros y/o las sales y/o hidratos y/o solvatos de los mismos; a los procesos para producir estos compuestos, a las composiciones farmacologicas que los contienen y a su utilizacion en la terapia y/o la prevencion de una condicion que requiere la modulacion de los receptores de la dopamina y/o 5-HT1A.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0500170A HUP0500170A3 (en) | 2005-02-03 | 2005-02-03 | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
| PCT/HU2006/000012 WO2006082456A1 (en) | 2005-02-03 | 2006-02-02 | Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007009353A true MX2007009353A (es) | 2007-09-21 |
Family
ID=89985795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007009353A MX2007009353A (es) | 2005-02-03 | 2006-02-02 | Ciclohexilamidas como antagonistas de la dopamina d3, d2 y 5ht1a. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7705003B2 (es) |
| EP (1) | EP1844030A1 (es) |
| JP (1) | JP2008528674A (es) |
| KR (1) | KR20070101265A (es) |
| CN (1) | CN101107236A (es) |
| AU (1) | AU2006211002A1 (es) |
| BR (1) | BRPI0606895A2 (es) |
| CA (1) | CA2594845A1 (es) |
| EA (1) | EA200701640A1 (es) |
| HU (1) | HUP0500170A3 (es) |
| IL (1) | IL183740A0 (es) |
| MA (1) | MA29250B1 (es) |
| MX (1) | MX2007009353A (es) |
| MY (1) | MY139750A (es) |
| NO (1) | NO20074447L (es) |
| TN (1) | TNSN07255A1 (es) |
| TW (1) | TWI311990B (es) |
| WO (1) | WO2006082456A1 (es) |
| ZA (1) | ZA200705839B (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1870405A1 (en) * | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
| HU230748B1 (hu) * | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
| HUP0700353A2 (en) | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| ES2653852T3 (es) * | 2007-08-03 | 2018-02-09 | Richter Gedeon Nyrt. | Composiciones farmacéuticas que contienen ligandos del receptor de dopamina y procedimientos de tratamiento usando ligandos del receptor de dopamina |
| US7875610B2 (en) | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| PT2317852E (pt) | 2008-07-16 | 2015-03-24 | Richter Gedeon Nyrt | Formulações farmacêuticas contendo ligandos de recetor de dopamina |
| HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
| HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
| HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
| US8586579B2 (en) | 2010-06-21 | 2013-11-19 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
| US8470828B2 (en) | 2010-07-06 | 2013-06-25 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
| US8877778B2 (en) | 2010-12-15 | 2014-11-04 | Hoffmann-La Roche Inc. | Benzofurane compounds |
| US8722683B2 (en) * | 2011-02-17 | 2014-05-13 | Hoffmann La-Roche Inc. | Benzodioxole piperazine compounds |
| US8921397B2 (en) | 2011-05-04 | 2014-12-30 | Hoffmann-La Roche Inc. | Benzofurane-piperidine compounds |
| US9376396B2 (en) | 2012-10-22 | 2016-06-28 | AbbVie Deutschland GmbH & Co. KG | Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
| UY35420A (es) | 2013-03-15 | 2014-10-31 | Abbvie Inc | Compuestos de acilaminocicloalquilo apropiados para tratar trastornos que responden a la modulación del receptor de dopamina d3 |
| AR095264A1 (es) | 2013-03-15 | 2015-09-30 | Abbvie Deutschland | Compuestos de acilaminocicloalquilo apropiados para tratar trastornos que responden a la modulación del receptor de dopamina d3 |
| CN104140421B (zh) | 2013-05-08 | 2017-04-05 | 上海医药工业研究院 | 苯并异噻唑类化合物及在制备抗精神分裂症药物中的应用 |
| WO2017045599A1 (zh) * | 2015-09-15 | 2017-03-23 | 浙江京新药业股份有限公司 | 环己烷衍生物或其立体异构体或盐及其制备与应用 |
| CN106518841B (zh) | 2015-09-15 | 2019-03-05 | 浙江京新药业股份有限公司 | 环己烷衍生物或其立体异构体或盐及其制备与应用 |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| US10870660B2 (en) | 2016-07-28 | 2020-12-22 | Shionogi & Co., Ltd. | Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect |
| EP3587398A4 (en) * | 2017-02-24 | 2020-01-01 | Shenzhen Linglan Bio-pharmaceutical Technology Co., Ltd | NOVEL SELECTIVE LIGAND FOR THE DOPAMINERGIC D3 RECEPTOR, CORRESPONDING PREPARATION METHOD AND CORRESPONDING PHARMACEUTICAL APPLICATION |
| US11447484B2 (en) | 2018-01-26 | 2022-09-20 | Shionogi & Co., Ltd. | Cyclic compound having dopamine D3 receptor antagonistic effect |
| BR112020014875A2 (pt) | 2018-01-26 | 2020-12-08 | Shionogi & Co., Ltd. | Composto cíclico condensado tendo antagonismo de receptor de dopamina d3 |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| WO2021088920A1 (zh) * | 2019-11-05 | 2021-05-14 | 上海翰森生物医药科技有限公司 | 苯并噻吩类衍生物调节剂、其制备方法和应用 |
| WO2024072930A1 (en) * | 2022-09-30 | 2024-04-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dopamine d3/d2 receptor partial agonists for the treatment of neuropsychiatric disorders |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763609A (en) | 1996-03-21 | 1998-06-09 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands |
| US5703083A (en) | 1996-04-15 | 1997-12-30 | Neurogen Corporation | N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands |
| US5703237A (en) | 1996-04-18 | 1997-12-30 | Neurogen Corporation | N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands |
| JPH10152470A (ja) | 1996-09-25 | 1998-06-09 | Yoshitomi Pharmaceut Ind Ltd | ピペラジン化合物 |
| KR100372926B1 (ko) * | 1998-06-02 | 2003-02-25 | 마쯔시다덴기산교 가부시키가이샤 | 고분자전해질형연료전지 및 그 제조방법 |
| SE9802208D0 (sv) | 1998-06-22 | 1998-06-22 | Astra Pharma Inc | Novel compounds |
| JP4156859B2 (ja) | 2001-06-20 | 2008-09-24 | コスモ石油株式会社 | 軽油の水素化処理触媒及びその製造方法並びに軽油の水素化処理方法 |
| HUP0103987A3 (en) | 2001-09-28 | 2004-11-29 | Richter Gedeon Vegyeszet | Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates |
| HU227543B1 (en) | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
-
2005
- 2005-02-03 HU HU0500170A patent/HUP0500170A3/hu unknown
-
2006
- 2006-01-27 MY MYPI20060390A patent/MY139750A/en unknown
- 2006-01-27 TW TW095103463A patent/TWI311990B/zh active
- 2006-02-02 WO PCT/HU2006/000012 patent/WO2006082456A1/en active Application Filing
- 2006-02-02 EA EA200701640A patent/EA200701640A1/ru unknown
- 2006-02-02 CA CA002594845A patent/CA2594845A1/en not_active Abandoned
- 2006-02-02 AU AU2006211002A patent/AU2006211002A1/en not_active Abandoned
- 2006-02-02 CN CNA2006800025267A patent/CN101107236A/zh active Pending
- 2006-02-02 US US11/814,874 patent/US7705003B2/en not_active Expired - Fee Related
- 2006-02-02 KR KR1020077015229A patent/KR20070101265A/ko not_active Application Discontinuation
- 2006-02-02 MX MX2007009353A patent/MX2007009353A/es not_active Application Discontinuation
- 2006-02-02 BR BRPI0606895-2A patent/BRPI0606895A2/pt not_active IP Right Cessation
- 2006-02-02 EP EP06710205A patent/EP1844030A1/en not_active Withdrawn
- 2006-02-02 JP JP2007553718A patent/JP2008528674A/ja not_active Withdrawn
-
2007
- 2007-06-07 IL IL183740A patent/IL183740A0/en unknown
- 2007-07-05 TN TNP2007000255A patent/TNSN07255A1/en unknown
- 2007-07-16 ZA ZA200705839A patent/ZA200705839B/xx unknown
- 2007-08-13 MA MA30137A patent/MA29250B1/fr unknown
- 2007-08-31 NO NO20074447A patent/NO20074447L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL183740A0 (en) | 2007-09-20 |
| TWI311990B (en) | 2009-07-11 |
| TNSN07255A1 (en) | 2008-12-31 |
| US7705003B2 (en) | 2010-04-27 |
| BRPI0606895A2 (pt) | 2009-07-21 |
| EP1844030A1 (en) | 2007-10-17 |
| JP2008528674A (ja) | 2008-07-31 |
| WO2006082456A1 (en) | 2006-08-10 |
| HUP0500170A2 (en) | 2006-11-28 |
| NO20074447L (no) | 2007-10-18 |
| TW200639158A (en) | 2006-11-16 |
| CA2594845A1 (en) | 2006-08-10 |
| HUP0500170A3 (en) | 2007-11-28 |
| AU2006211002A1 (en) | 2006-08-10 |
| HU0500170D0 (en) | 2005-04-28 |
| US20080103140A1 (en) | 2008-05-01 |
| MA29250B1 (fr) | 2008-02-01 |
| CN101107236A (zh) | 2008-01-16 |
| MY139750A (en) | 2009-10-30 |
| KR20070101265A (ko) | 2007-10-16 |
| ZA200705839B (en) | 2009-05-27 |
| EA200701640A1 (ru) | 2008-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007009353A (es) | Ciclohexilamidas como antagonistas de la dopamina d3, d2 y 5ht1a. | |
| RS20060041A (en) | Carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists | |
| UA107657C2 (uk) | Похідні бензофурану | |
| TW200716528A (en) | Cyclopropanecarboxamide derivatives | |
| TW200718692A (en) | Dihydrobenzofuran derivatives and uses thereof | |
| MXPA05011670A (es) | Derivados de azetidincarboxamida y su uso en el tratamiento de trastornos mediados por el receptor cb1. | |
| TW200726470A (en) | 6,7-unsaturated-7-carbamoylmorphinan derivatives | |
| TW200621694A (en) | Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds | |
| PL1831152T3 (pl) | Pochodne tetraliny i indanu oraz ich zastosowanie jako antagonistów 5-HT | |
| MX2012006789A (es) | Derivados de etinilo. | |
| CO5700763A2 (es) | Derivados de 1-bencil-5-piperazin-1-il-3,4-dihidro-1h-quinazolin-2-ona y el respexctivo 1h-benzo (1,2,6)tiadiazin-2,2-dioxido y derivados de 1,4-dihidro-benzo (d) (1,3) oxazin-2-ona como moduladores del receptor 5-hidroxitriptamina (5-ht) para el tra | |
| MX2009003927A (es) | Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes. | |
| TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
| PL1831191T3 (pl) | Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HT | |
| MY148384A (en) | Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands | |
| PL1893589T3 (pl) | PODSTAWIONE POCHODNE N-BENZO[D]IZOKSAZOL-3-ILOAMINY JAKO INHIBITORY RECEPTORÓW mGluR5, SEROTONINY (5-HT) I NORADRENALINY I ICH ZASTOSOWANIE DO WYTWARZANIA ŚRODKÓW LECZNICZYCH | |
| MY161992A (en) | Novel tetrahydroisoquinoline derivative | |
| MY164789A (en) | Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine | |
| TW200517387A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
| TNSN06337A1 (en) | 6-substituted pyridoindolone derivatives production and therapeutic use thereof | |
| GB0617867D0 (en) | Chemical compounds | |
| MY136910A (en) | NEW 4-OXO-4,6,7,8-TETRAHYDRO-PYRROLO[1,2-a]PYRAZINE-6-CARBOXAMIDE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| TW200801016A (en) | Thienopyridine-2-carboxamide derivatives | |
| MXPA03002532A (es) | Nuevos compuestos de indolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| CU23563A3 (es) | Derivados de (tio) carbamoil-ciclohexano como antagonistas del receptor d3/d2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |